TP53 and neoplasm: It has been demonstrated that wtp53 can be degraded by mouse double minute 2 (MDM2) ubiquitin ligase and that p53 mutants, although still interacting with MDM2, can evade MDM2-mediated ubiquitination and degradation, at least in the context of tumor cells [24].